Related Experiment Video
Updated: Mar 18, 2026

Isolation of Mouse Lung Dendritic Cells
Published on: November 22, 2011
Disruption of Early Tumor Necrosis Factor Alpha Signaling Prevents Classical Activation of Dendritic Cells in
Jintao Xu1, Alison J Eastman2, Adam Flaczyk1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA Pulmonary Section, Medical Service, Ann Arbor VA Health System, Department of Veterans Affairs Health System, Ann Arbor, Michigan, USA.
Unlabelled:
Anti-tumor necrosis factor alpha (anti-TNF-α) therapies have been increasingly used to treat inflammatory diseases and are associated with increased risk of invasive fungal infections, including Cryptococcus neoformans infection. Using a mouse model of cryptococcal infection, we investigated the mechanism by which disruption of early TNF-α signaling results in the development of nonprotective immunity against C. neoformans We found that transient depletion of TNF-α inhibited pulmonary fungal clearance and enhanced extrapulmonary dissemination of C. neoformans during the adaptive phase of the immune response. Higher fungal burdens in TNF-α-depleted mice were accompanied by markedly impaired Th1 and Th17 responses in the infected lungs. Furthermore, early TNF-α depletion also resulted in disrupted transcriptional initiation of the Th17 polarization program and subsequent upregulation of Th1 genes in CD4(+) T cells in the lung-associated lymph nodes (LALN) of C. neoformans-infected mice. These defects in LALN T cell responses were preceded by a dramatic shift from a classical toward an alternative activation of dendritic cells (DC) in the LALN of TNF-α-depleted mice. Taken together, our results indicate that early TNF-α signaling is required for optimal DC activation, and the initial Th17 response followed by Th1 transcriptional prepolarization of T cells in the LALN, which further drives the development of protective immunity against cryptococcal infection in the lungs. Thus, administration of anti-TNF-α may introduce a particularly greater risk for newly acquired fungal infections that require generation of protective Th1/Th17 responses for their containment and clearance.
Importance:
Increased susceptibility to invasive fungal infections in patients on anti-TNF-α therapies underlines the need for understanding the cellular effects of TNF-α signaling in promoting protective immunity to fungal pathogens. Here, we demonstrate that early TNF-α signaling is required for classical activation and accumulation of DC in LALN of C. neoformans-infected mice. Subsequent transcriptional initiation of Th17 followed by Th1 programming in LALN results in pulmonary accumulation of gamma interferon- and interleukin-17A-producing T cells and effective fungal clearance. All of these crucial steps are severely impaired in mice that undergo anti-TNF-α treatment, consistent with their inability to clear C. neoformans This study identified critical interactions between cells of the innate immune system (DC), the emerging T cell responses, and cytokine networks with a central role for TNF-α which orchestrate the development of the immune protection against cryptococcal infection. This information will be important in aiding development and understanding the potential side effects of immunotherapies.
Insights
Early tumor necrosis factor alpha (TNF-α) signaling is crucial for immune cells to fight fungal infections like Cryptococcus neoformans. Blocking TNF-α impairs T cell responses and increases fungal spread, highlighting risks of anti-TNF-α therapies.
Area of Science:
- Immunology
- Microbiology
- Pharmacology
Background:
- Anti-tumor necrosis factor alpha (anti-TNF-α) therapies are widely used for inflammatory diseases.
- These therapies are linked to an increased risk of invasive fungal infections, including Cryptococcus neoformans.
- Understanding the role of TNF-α in protective immunity against fungal pathogens is critical.
Purpose of the Study:
- To investigate how disrupting early TNF-α signaling affects immune responses to Cryptococcus neoformans.
- To elucidate the mechanism by which TNF-α signaling promotes protective immunity against fungal infections.
- To identify the cellular and molecular events orchestrated by TNF-α in antifungal immunity.
Main Methods:
- Utilized a mouse model of cryptococcal infection.
- Administered transient depletion of TNF-α to assess its impact on immune responses.
- Analyzed T cell responses (Th1 and Th17) in lungs and lung-associated lymph nodes (LALN).
- Investigated dendritic cell (DC) activation and polarization in LALN.
Main Results:
- Transient TNF-α depletion inhibited pulmonary fungal clearance and promoted extrapulmonary dissemination of C. neoformans.
- Impaired Th1 and Th17 responses were observed in the lungs of TNF-α-depleted mice.
- Early TNF-α depletion disrupted Th17 and Th1 transcriptional programming in LALN T cells.
- A shift from classical to alternative DC activation occurred in the LALN of TNF-α-depleted mice.
Conclusions:
- Early TNF-α signaling is essential for optimal DC activation and subsequent Th17/Th1 T cell polarization in LALN.
- This process is critical for developing protective immunity against C. neoformans in the lungs.
- Anti-TNF-α therapies may increase the risk of new fungal infections requiring Th1/Th17 responses for control.

